All News

In a recent study at the National Institutes of Health, researchers consistently observed signs of damage on the brain scans of patients who died after contracting COVID-19.

Pralatrexate, a lymphoma drug, outperformed remdesivir in treating COVID-19 in a lab experiment.

The first article in this 3-part series covered a general overview of the survey and its respondents. In this article, we will explore the questions and answers around compensation.

According to the study authors, this could lead to finding the exact molecular trigger and gives hope for developing a targeted PsA treatment in the future.

In the 16th century, it was quite easy to obtain poison, as apothecaries were in the business of making customers happy and the opportunity to poison people was one such source of joy.

FDA approves request submitted by Moleculin Biotech, Inc. for rare disease designations to be granted their drug candidate that appears to directly elicit tumor cell death and prompt the immune system to eliminate tumors.

Pharmacists must juggle the delicate balance of integrating clinical services into traditional dispensing environments, while being forced into performance metrics set forth by corporate entities.

Socioeconomic and racial health disparities contribute to worse cancer and COVID-19 outcomes.

According to the study authors, previous small studies suggested that women taking statins may have less heart muscle damage from these types of chemotherapy, yet the exact mechanisms of how statins protect against the cardiac cell damage remains unknown.

A recent study investigated the existence of “pharmacy deserts” in Los Angeles County in relation to the social determinants of health that show which communities have the greatest need for pharmacy access.

The study, which appears in The New England Journal of Medicine, is the largest to-date to compare thresholds for blood transfusions in premature babies, according to the press release.

The FDA has granted a breakthrough therapy designation to tiragolumab for use in combination with atezolizumab (Tecentriq) in the frontline treatment of patients with metastatic non­–small cell lung cancer.

The company began administering COVID-19 vaccines to residents and staff at long-term care facilities in late December as part of the CDC Pharmacy Partnership for Long-term Care Program.

Chronic, low-level inflammation is one of the main causes of the diseases associated with obesity. For this reason, researchers investigated which cell type was responsible for triggering inflammation in fat tissue.

This study points to the potential for using CAR T-cell therapy effectively against solid tumors, as well, according to the authors.

Reflection is a key strategy to facilitate self-identity and other aspects of personal development that benefit pharmacy practice.

Despite fringe conspiracy theories that circulated online, COVID-19 carries a greater risk of health problems than the flu.